Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Life Sciences
|
July 7, 2007
Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells
Mariko Hokari, Yasunobu Matsuda, Toshifumi Wakai, et al.
International Journal of Clinical and Experimental Pathology
|
June 27, 2014
Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinase
Yasunobu Matsuda, Ayumi Sanpei, Toshifumi Wakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
September 11, 2013
Double staining with crystal violet and methylene blue is appropriate for colonic endocytoscopy: an in vivo prospective pilot study
Katsuro Ichimasa, Shin-ei Kudo, Yuichi Mori, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 6, 2003
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis
Kenta Suzuki, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences
|
February 12, 2002
Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients
Mitsuhiro Takimoto, Shogo Ohkoshi, Takafumi Ichida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 18, 2013
Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression
Masahiko Yano, Shogo Ohkoshi, Yo-hei Aoki, et al.
Hepato-Gastroenterology
|
August 12, 2011
Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy
Shogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, et al.
Hepatology International
|
August 12, 2009
Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B
Shogo Ohkoshi, Akira Yoshimura, Satoshi Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 29, 2011
Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C
Yo-Hei Aoki, Shogo Ohkoshi, Satoshi Yamagiwa, et al.
World Journal of Hepatology
|
February 11, 2011
Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
Hirokazu Kawai, Minoru Nomoto, Takeshi Suda, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Life Sciences
|
July 7, 2007
Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells
Mariko Hokari, Yasunobu Matsuda, Toshifumi Wakai, et al.
International Journal of Clinical and Experimental Pathology
|
June 27, 2014
Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinase
Yasunobu Matsuda, Ayumi Sanpei, Toshifumi Wakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
September 11, 2013
Double staining with crystal violet and methylene blue is appropriate for colonic endocytoscopy: an in vivo prospective pilot study
Katsuro Ichimasa, Shin-ei Kudo, Yuichi Mori, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 6, 2003
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis
Kenta Suzuki, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences
|
February 12, 2002
Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients
Mitsuhiro Takimoto, Shogo Ohkoshi, Takafumi Ichida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 18, 2013
Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression
Masahiko Yano, Shogo Ohkoshi, Yo-hei Aoki, et al.
Hepato-Gastroenterology
|
August 12, 2011
Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy
Shogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, et al.
Hepatology International
|
August 12, 2009
Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B
Shogo Ohkoshi, Akira Yoshimura, Satoshi Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 29, 2011
Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C
Yo-Hei Aoki, Shogo Ohkoshi, Satoshi Yamagiwa, et al.
World Journal of Hepatology
|
February 11, 2011
Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
Hirokazu Kawai, Minoru Nomoto, Takeshi Suda, et al.
Page
of 5